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ER quality controld by the mutation in CF transmembrane conductance regulator (CFTR), a cAMP-
dependent Cl− channel at the plasma membrane of epithelium. The most common mutant, ΔF508 CFTR, has
competent Cl− channel function, but fails to express at the plasma membrane since it is retained in the
endoplasmic reticulum (ER) by the ER quality control system. Here, we show that calnexin (CNX) is not
necessary for the ER retention of ΔF508 CFTR. Our data show that CNX knockout (KO) does not affect the
biosynthetic processing, cellular localization or the Cl− channel function of ΔF508 CFTR. Importantly, cAMP-
induced Cl− current in colonic epithelium from CNX KO/ΔF508 CFTR mice was comparable with that of ΔF508
CFTR mice, indicating that CNX KO failed to rescue the ER retention of ΔF508 CFTR in vivo. Moreover, we
show that CNX assures the efﬁcient expression of WT CFTR, but not ΔF508 CFTR, by inhibiting the
proteasomal degradation, indicating that CNX might stimulate the productive folding of WT CFTR, but not
ΔF508 CFTR, which has folding defects.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Cystic ﬁbrosis transmembrane conductance regulator (CFTR) is a
polytopic integral membrane protein that functions as a cAMP-
dependent Cl− channel in the apical membrane of epithelial cells[1–4].
Mutations in the CFTR gene lead to the absence or malfunction of a
regulated Cl− channel in the apical membrane of secretory epithelium,
resulting in the clinical symptoms of cystic ﬁbrosis (CF), which is a
common genetic disease in Caucasians[5–8]. More than 1300 CFTR
mutations have been reported [9], but over 90% of CF patients carry at
least one allele of the Phe508 deletion (ΔF508 CFTR). Although ΔF508
CFTR functions as a cAMP-dependent Cl− channel in model situations
where it reaches the plasma membrane [2,10,11], it fails to express at
the plasma membrane because it is retained in the endoplasmic
reticulum (ER), leading to its ubiquitination and proteasomal
degradation, which is known as the ER-associated degradation
(ERAD)[12–18]. Since ΔF508 CFTR has competent function as a reg-
ulated Cl− channel, it is very important to understand the molecular
mechanism of the ER retention of ΔF508 CFTR for the development ofai).
l rights reserved.a therapeutic approach to CF. However, the molecular mechanism of
ER retention is not fully understood, but the folding defect of ΔF508
CFTR, which is recognized by the ER quality control system, is believed
to be responsible for its ER retention[19–21].
Previous studies indicate that the ER retention of ΔF508 CFTR
might result from 1) aberrant chaperone binding[22–24] or 2)
defective recognition by the ER export machinery [19,20]. However,
addition of the ER export signal into ΔF508 CFTR failed to rescue the
ER retention [25], indicating that aberrant chaperone binding is likely
responsible for the ER retention. ΔF508 CFTR interacts with cytosolic
chaperones, Hsc/Hsp70, Hsp90, Hsp40/Hdj2, HspBP1[22,26–28] and
an ER chaperone calnexin (CNX) [23,29,30]. These ΔF508 CFTR
“chaperome” could deﬁne the success or failure of ΔF508 CFTR folding
and the ER export [24]. In fact, down-regulation of Aha1, a Hsp90
cochaperone, corrected the ER retention of ΔF508 CFTR [24]. More-
over, prolonged interaction with CNX was observed in ΔF508 CFTR
[23], and some compounds such as thapsigargin and curcumin that
might affect the interaction of ΔF508 CFTR with CNX, corrected the ER
retention of ΔF508 CFTR[31–33]. Thus, similar to Hsp90-Aha1
cytosolic chaperones, an ER chaperone CNX seems to be responsible
for the ER retention of ΔF508 CFTR. Contrary to this hypothesis, a
recent report showed that moderate CNX knockdown (60–70%
knockdown) by the RNA interference technique failed to improve
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indicating that CNX might not be responsible for the ER retention of
ΔF508 CFTR. However, it is possible that the remaining activity of CNX
(~30%) could be involved in the ER retention of ΔF508 CFTR in CNX-
knockdown cells. Moreover, the cellular localization and function of
ΔF508 CFTR, which are important for evaluating the rescue effect on
the ER retention of ΔF508 CFTR, have not been examined in CNX-
knockdown cells [30]. Therefore, it remains unclear whether CNX is
necessary for the ER retention of ΔF508 CFTR.
In this study, to clarify whether CNX is necessary in the ER
retention of ΔF508 CFTR, we utilized CNX knockout (KO) systems. Our
data showed that CNX KO did not affect the ER retention of ΔF508
CFTR in mouse embryonic ﬁbroblast (MEF) from CNX knockout (KO)
mice. Most importantly, function of ΔF508 CFTR was not corrected in
the polarized colon epithelium from CNX KO/ΔF508 CFTR mice. These
results clearly demonstrate that CNX is not necessary for the ER
retention of ΔF508 CFTR in vivo. Moreover, we utilized CNX KOMEF to
determine the role of CNX in the productive folding of CFTR. Our data
indicate that CNX might stimulate the productive folding of WT CFTR,
which can correctly fold, but not that of ΔF508 CFTR, which has
folding defects.
2. Materials and methods
2.1. Materials, DNA constructs and recombinant adenovirus
Most of the antibodies used in this study have been reported [29]. Mouse
monoclonal anti-CFTR (clone 24-1; Genzyme/Techne), rabbit polyclonal anti-calnexin
(anti-CNX; SPA-860; Stressgen Biotechnologies Corp.), mouse monoclonal anti-Hsp70
(clone C92F3A-5; Stressgen Biotechnologies Corp.), rat monoclonal anti-Hsc70
(clone 1B5, SPA-815, Stressgen Biotechnologies Corp.), rabbit polyclonal anti-
calreticulin (anti-CRT; SPA-600; Stressgen Biotechnologies Corp.), mouse mono-
clonal anti-KDEL (anti-BiP; clone 10C3; Stressgen Biotechnologies Corp.), and mouse
monoclonal anti-GM130 antibody (clone 35 was purchased from BD Biosciences,
Franklin Lakes, NJ). Castanospermine (CAS) was purchased from SIGMA (St. Louis,
MO). Several CNX mutants were constructed with standard methods and veriﬁed by
sequencing. C-terminus fusions of CNX mutants with c-Myc were designed by
inserting cDNA in-frame into pCMV-Tag5A vector (Stratagene, La Jolla, CA) using
BamHI and EcoRI sites. Recombinant adenoviruses expressing human CNX (Ad-CNX),
CRT (Ad-CRT) and LacZ (Ad-LacZ) based on adenovirus 5 (Ad5) were produced as
described previously [29,34]. Recombinant adenovirus expressing human GFP-CFTR
(Ad-GFP-CFTR) and GFP-ΔF508 CFTR (Ad-GFP-ΔF508) were obtained from Dr. JM.
Wilson (University of Pennsylvania) [35].
2.2. Cell cultures and transfection
CFTR-BHK, ΔF508-BHK, CFTR-CHO and ΔF508-CHO cells were grown and
maintained as described previously[1–3]. Transfection and adenovirus infection were
performed as described previously [1,2]. Cells were incubated with 1 mM (CFTR- and
ΔF508-BHK cells) or 2 mM sodium butyrate (CFTR- and ΔF508-CHO cells) for 20–24 h
before experiments.
2.3. Calnexin knockout cells
Calnexin+/− mice were generated by deleting ﬂoxed exon 3 and 4 by conditional
gene targeting (unpublished data, M. Ikawa). Embryonic ﬁbroblasts were prepared from
E14.5 fetus obtained by heterozygous intercross. Mouse embryonic ﬁbroblast (MEF) was
maintained in DMEM medium containing 10% FBS and antibiotics. Recombinant
adenovirus infection was performed as described previously [29,34].
2.4. SDS-PAGE and Western blotting
SDS-PAGE and Western blotting were performed as described previously [29].
Subconﬂuent (90–100%) cells grown on six-well plates were washed twice with ice-
cold PBS and lysed at 4 °C in RIPA buffer (50 mM Tris–HCl, 150 mM NaCl, 1 mg/ml
sodium deoxycholate and 1% NP-40) containing 1% protease inhibitor cocktail (SIGMA)
and centrifuged at 15,000 g for 10 min at 4 °C. The supernatant (cell lysate) was
subjected to SDS-PAGE on 5% or 7.5% polyacrylamide gels. For N-glycanases digestion,
cell lysates were denatured at 30 °C for 10 min and digested with Endo H (500 U, New
England Biolab, Beverly, MA) or PNGase F (500 U, New England BioLab) at 30°°C for 3 h.
Digestion was stopped by adding SDS sample buffer and the digested lysate was
subjected to SDS-PAGE andWestern blotting. Blotted PVDFmembranes were blocked in
0.05% Tween 20 in PBS supplementing 5% skim milk for 1 h at RT. Antibody reaction
with the indicated antibodies in the ﬁgure legends was carried out as previously
described [29]. ECL detection reagents (Amersham Pharmacia Biotech) or SuperSignal®West Pico Chemiluminescent Substrate (Pierce Biotechnology, Rockford, IL) were used
for chemiluminescence and blots were visualized using Luminescent Image Analyzer
(LAS-1000, FUJIFILM). The expression level of CFTR was quantiﬁed using Image Gauge
software (Ver. 3.4, FUJIFILM, Japan) and indicated as mean values±S. E. M. (N=3–4).
Data were evaluated for statistical differences by analysis of t-test with Microsoft Excel.
2.5. Immunoprecipitation
For immunoprecipitation, cells were lysed with 0.5% digitonin buffer (50 mM Tris
(pH 8), 150 mMNaCl, 0.5% digitonin) containing 1% protease inhibitor cocktail (SIGMA).
Cell lysates were incubated for 12 h at 4 °C with anti-CFTR antibody immobilized in
protein G Sepharose® 4 Fast Flow (Amersham Bioscience, Uppsala, Sweden).
Immunoprecipitants were washed in 0.1% digitonin buffer 5 times, eluted in 2× SDS
sample buffer and analyzed with Western blotting.
2.6. Immunocytochemical analysis using a confocal laser scanning microscopy
Immunocytochemical analyses were performed as described previously [29]. Cells
were stained with the indicated primary antibodies (1:100 dilution) in 1% BSA/PBS and
with Alexa Fluor® 546- (Molecular Probes, Inc., Eugene, OR) or Cy5-conjugated
secondary antibodies (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) in
1% BSA/PBS at room temperature. Cells werewashed three timeswith PBS andmounted
with VECTASHIELD® mounting medium (Vector Laboratories, Burlingame, CA). Cells
were observed and analyzed using FLUOVIEW FV300 or FV500 confocal laser scanning
microscopes (OLYMPUS, Tokyo, Japan).
2.7. 125I efﬂux experiments
125I efﬂux experiments were performed as described previously [34]. The
percentage efﬂux was calculated as follows: % efﬂux (E)= (count secreted) / (total count
remaining in the cells)×100. The increase ratio (EcAMP /Epre) was calculated as follows:
ratio (EcAMP /Epre)=(% efﬂux after cAMP stimulation) / (% efﬂux of pre-stimulation). Data
are expressed as mean values±S. E. M. (N=3). Data were evaluated for statistical
differences by analysis of t-test with Microsoft Excel.
2.8. Calnexin knockout/ΔF508 CFTR mice
ES cells with a deletion of one CNX allele were created by a gene-trap approach to
interrupt a coding region of the gene [4,5]. This was achieved by a knock-in of the β-
galactosidase gene [4,5]. These cells were created at BayGenomics (BayGenomics,
http://baygenomics.ucsf.edu/) and used directly to generate cnx+/− and subsequently
cnx−/− mice. ES cells were microinjected into 3.5-day-old C57BL/6J blastocysts to
generate chimeric mice. Chimeric males were analyzed for germline transmission by
mating with C57BL/6J females, and the progeny were analyzed by PCR, Southern blot
and Western blot analyses. cnx−/− mice were smaller than their siblings, developed
severe motor problems of their lower limbs and have difﬁculties with maintaining a
proper balance as described previously [6]. In contrast to the report by Denzel et al. [52],
these mice were viable for up 2 years. The complete phenotype developed at 2 weeks
after birth and did not progress. Calnexin-deﬁcient mice were crossed with CF mice and
selected by PCR for CF homozygotes and calnexin knockout animals.
2.9. Short-circuit current experiments in CNX KO/ΔF508 CFTR mice
The breeding colony of CFmice (B6.129S6-Cftrtm1Kth, Jackson Laboratory, Bar Harbor,
ME) was housed in a speciﬁc pathogen-free environment (Health Sciences Laboratory
Animal Services, University of Alberta). All experiments described in this study were
carried out with the approval of the Health Sciences Animal Policy and Welfare
Committee, University of Alberta. Mice were killed by CO2 narcosis, and 6 cm-long
pieces of colonwere removed from ~2 cm below the caecum and immediately placed in
cold Krebs–Henseleit solution (KHS) containing (mM): 116 NaCl, 4.7 KCl, 2.5 CaCl2, 1.2
MgCl2, 25 NaHCO3,1.2 KH2PO4, and 11.1 glucose, pH 7.4. The colons were opened up, and
the muscle layers were dissected away. Pieces of 0.2 cm2 were taken from the colon and
mounted in Ussing chambers. Ussing chamber short-circuit current (Isc) experiments
were performed as described in previous studies [36].
3. Results
3.1. Effect of CNX truncated mutant on the ER retention of ΔF508 CFTR
To determine the role of CNX in the ER retention ofΔF508 CFTR, we
ﬁrst constructed several truncated CNXmutants tagged with c-Myc at
the C-terminus (Fig. 1A, B) because the CNX truncated mutant, which
is exported from the ER, induced the ER export of aberrant proteins
retained in the ER by CNX [7,8]. To examine the cellular localization of
CNXmutants, they were expressed in BHK cells stably expressing GFP-
ΔF508 CFTR (ΔF508-BHK, Fig. 1C). Immunocytochemical analyses
showed that among the CNX mutants we constructed, a CNX mutant
Fig. 1. Effect of CNX truncated mutants on the ER retention of ΔF508 CFTR. (A) Schematic model of CNX truncated mutants. CNX mutants were tagged in the C-terminus with c-Myc.
TM and RKPRRE indicate transmembrane domain and the ER localization signal, respectively. (B) Expression of CNX mutants. Cell lysates from CFTR-CHO cells transfected with
several CNX mutants were analyzed by Western blotting with anti-Myc antibody. Hsc70 was used as a loading control. (C) Cellular localization of CNX mutants. CNX mutants were
expressed in BHK cells, immunostained with anti-Myc antibody and analyzed using a confocal laser scanning microscope. Bar, 10 μm. (D) Interaction of CNXΔCYT with ΔF508 CFTR.
ΔF508 CFTR-CHO cells transfected with CNXΔCYT were treated with 5 μg/ml BFA for 6 h and lysed in 0.5% digitonin buffer. Cell lysates were immunoprecipitated with anti-CFTR
antibody and the precipitants were analyzed byWestern blotting. (E) Effect of CNXΔCYT in the ER localization of ΔF508 CFTR. ΔF508 CFTR-BHK cells transfected with CNXΔCYT were
ﬁxed 48 h after transfection, immunostained with anti-Myc and -KDEL (BiP, ER marker) or -GM130 (Golgi marker) antibodies and visualized with Alexa Fluor 546- and Cy5-
conjugated secondary antibodies. Bars,10 μm. (F) Effect of CNXΔCYTon the function ofΔF508 CFTR.ΔF508-CHO cells were transfectedwith CNX (Full), CNXΔCYTor incubated at 26 °C
for 48 h. Forty-eight hours after transfection, cells were loaded with 125I (100 μCi/ml) for 1 h. After washing, cells were stimulated by cAMP cocktail for 5 min and 125I efﬂux was
measured as described in Materials and methods. Data are expressed as mean values±S. E. M. (N=3). Statistical differences are shown as ⁎⁎Pb0.01 and ⁎Pb0.05 against ΔF508-CHO
cells (mock). (G) ΔF508 CFTR was rescued after low temperature incubation. ΔF508-BHK cells were incubated at 26 °C for 48 h and analyzed using a confocal laser scanning
microscope. Note that after 26 °C incubation, ΔF508 CFTR left the ER to the Golgi and plasma membrane (arrowheads).
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the juxta-nuclear region, indicating that CNXΔCYT could be exported
from the ER (Fig. 1C). Immunoprecipitation experiments revealed that
CNXΔCYT interacted with ΔF508 CFTR in the ER similar to full lengthFig. 2. CFTR expression in CNX KO MEF. (A) CNX and other chaperones expression in CNX KO
blotting with the antibodies indicated. β-actin was used as loading control. (B–D) CFTR expre
GFP-CFTR or −ΔF508 CFTR at a MOI 100 were lysed 48 h after infection and analyzed by W
mature form of CFTR, respectively. Hsc70was used as loading control. The intensity of the CFT
(D). Data are expressed as mean values±S. E. M. (N=3–4). Statistical differences are shown a
and ΔF508 CFTR in cell lysates fromWTMEF (E) or CNX KO MEF (F) were digested with Endo
non-glycosylated CFTR. As a positive control, cell lysate from CHO cells expressing WT CFTRCNX (Fig. 1D). Immunocytochemical analysis showed that upon
overexpression of CNXΔCYT, ΔF508 CFTR was still co-localized with
an ER marker, BiP, but not a Golgi marker GM130, indicating that
CNXΔCYT did not affect the ER localization of ΔF508 CFTR (Fig. 1E) inMEF. Cell lysates fromWT MEF (WT) and CNX KO MEF (KO) were analyzed byWestern
ssion in CNX KO MEF. WT MEF (B) and CNX KO MEF (C, D) infected with or without Ad-
estern blotting with anti-CFTR antibody. Bands B and C represent immature form and
R band was quantiﬁed and expressed as a percentage of the CFTR expression inWTMEF
s ⁎⁎Pb0.01 against WT MEF. (E, F) N-glycosidases digestion of CFTR in CNX KO MEF. WT
H (500 U) or PNGase F (500 U), and analyzed byWestern blotting. Band A indicates the
(CFTR in CHO) was loaded in lane 7.
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CNXΔCYT on the function of ΔF508 CFTR by 125I efﬂux assay since this
functional assay is muchmore sensitive. Fig. 1F showed that CNXΔCYT
did not correct the function of ΔF508 CFTR while low temperature
incubation, which rescues ΔF508 CFTR [9] (Fig. 1G), corrected the
function. Taken together, these results indicate that CNX might not be
involved in the ER retention of ΔF508 CFTR.
3.2. Wild-type and ΔF508 CFTR expression in CNX KO MEF
To further elucidate whether CNX is responsible for the ER
retention of ΔF508 CFTR, we utilized mouse embryonic ﬁbroblast
(MEF) from CNX knockout (KO) mice. Western blotting showed that
the endogenous CNX was undetectable in CNX KO MEF (Fig. 2A).
Expressions of chaperones such as calreticulin (CRT), Hsp70, Hsc70,
Hsp90 and Hsp40, that participated in CFTR biosynthesis
[22,26,27,37], were comparable between WT and CNX KO MEF.
Similarly, BiP and Grp94 were not increased, indicating no ER stress
response in CNX KO MEF.Fig. 3. ΔF508 CFTR is retained in the ER in CNX KOMEF. (A–C) Intracellular localization of CFT
(B) at a MOI 100 were immunostained with anti-KDEL (BiP) and −CNX antibodies 48 h after in
CFTR can be rescued in CNX KO MEF. WT and CNX KO MEF infected with Ad-GFP-CFTR or −
ΔF508). CFTR localization was analyzed using a confocal laser scanning microscopy. Bars, 10 μ
CFTR (+CFTR, MOI 100) or −ΔF508 CFTR (+ΔF508, MOI 100). Forty-eight hours after infection,
expressed as mean values±S. E. M. (N=3). Statistical differences are shown as ⁎⁎Pb0.01 andWild-type (WT) and ΔF508 CFTR were introduced in WT MEF and
CNX KO MEF by infection of the adenovirus expressing CFTR-GFP.
Western blotting showed that both WT and ΔF508 CFTR were
speciﬁcally detected by anti-CFTR antibody (Fig. 2B). WT CFTR was
expressed as ~200 kDa and ~170 kDa bands in both WT and CNX KO
MEF (Fig. 2C). Glycosidase digestion revealed that the ~200 kDa band
was the mature (complex-glycosylated) form since it was Endo H-
insensitive, but PNGase F-sensitive (Fig. 2E, F). The lower band
(~170 kDa) was both Endo H- and PNGase F-sensitive, indicating
immature (core-glycosylated) CFTR (Fig. 2E, F). In CNX KOMEF, steady
state level ofWT CFTRwas signiﬁcantly decreased comparedwith that
in WT MEF (Fig. 2D), indicating that CNX assures the efﬁcient CFTR
biosynthesis as suggested previously [29,30].
Similar to previous studies using several cell models, ΔF508 CFTR
was expressed in WT MEF as an immature form, which was Endo H-
sensitive (Fig. 2E). In contrast to WT CFTR, steady state level of ΔF508
CFTR was not signiﬁcantly decreased in CNX KO MEF compared with
that in WT MEF (Fig. 2C, D). Although an immature form of ΔF508
CFTR, which was Endo H-sensitive, was detected similarly to WTMEF,R in CNX KOMEF. WT and CNX KOMEF infected with Ad-GFP-CFTR (A) or −ΔF508 CFTR
fection, and analyzed using a confocal laser scanningmicroscope. Bars, 10 μm. (C)ΔF508
ΔF508 CFTR at a MOI 100. ΔF508 CFTR was rescued by 26 °C incubation for 48 h (Res
m. (D) CFTR function in CNX KO MEF. WT and CNX KO MEF were infected with Ad-GFP-
cAMP-induced 125I efﬂuxwasmeasured as described inMaterials andmethods. Data are
⁎Pb0.05 against uninfected MEF.
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(Fig. 2F), indicating that ΔF508 CFTR might be retained in the ER in
CNX KO MEF.
3.3. Cellular localization and function of ΔF508 CFTR in CNX KO MEF
To determine the cellular localization of ΔF508 CFTR in CNX KO
MEF, we performed immunocytochemical analysis using a confocal
laser scanning microscopy. Similar to previous reports, WT CFTR was
expressed at the plasmamembrane inWTMEF (Fig. 3A-a). In contrast,
ΔF508 CFTR was localized in the peri-nuclear regions, overlapping
with an ERmarker BiP, indicating thatΔF508 CFTRwas localized in the
ER in WT MEF (Fig. 3B-a). In CNX KO MEF, cellular localization of both
WT and ΔF508 CFTR was not changed compared with that in WTMEF
(Fig. 3A, B). ΔF508 CFTR was still co-localized with BiP in CNX KOMEF,
indicating that ΔF508 CFTR was localized in the ER in CNX KO MEF
(Fig. 3B-b). To rule out the possibility that ΔF508 CFTR cannot be
rescued in MEF, we tried the low temperature (26 °C) rescue of ΔF508
CFTR in MEF. Fig. 3C showed that in both WT and CNX KO MEFs, low
temperature incubation induced the cell surface expression of ΔF508
CFTR. Thus, ΔF508 CFTRmight be rescued in MEF similar to other cells
[9].Fig. 4. ΔF508 CFTR function in colonic epithelium of CNX KO/ΔF508CFTR mice. (A–D) Short-c
forskolin (10 μM, both sides) and furosemide (1 mM, basolateral) inWT (A), ΔF508 CFTR (B), C
of 16,12,16 and 4 recordings fromWT, ΔF508 CFTR, CNX KO, and CNX KO/ΔF508 CFTR colonic
type mouse tail (wt) and CNX KO (cnx−/−) mouse tail were analyzed by Western blotting wiTo exclude the possibility that a very small fraction of ΔF508 CFTR,
which failed to be detected by both Western blotting and immuno-
cytochemistry, left the ER to the plasma membrane, we performed
cAMP-induced 125I efﬂux assay as a functional marker of CFTR. While
cAMP-induced 125I efﬂux was not observed in the WT MEF, in which
CFTR was not introduced (Fig. 3D, uninfected), it was observed in WT
MEF expressing WT CFTR (Fig. 3D, WT +CFTR), indicating that the
cAMP-induced 125I efﬂux was mediated by cell surface WT CFTR.
Interestingly, the halide efﬂux mediated by WT CFTR was moderately
decreased in CNX KO MEF compared with that in WT MEF (Fig. 3D,
CNX KO +CFTR). In WT MEF expressing ΔF508 CFTR, the cAMP-
induced 125I efﬂux was not observed (Fig. 3D, WT +ΔF508), indicating
that ΔF508 CFTR did not express at the plasma membrane. Similar to
that in WT MEF, the cAMP-induced 125I efﬂux was not observed in
CNX KO MEF expressing ΔF508 CFTR (Fig. 3D, CNX KO +ΔF508),
indicating that ΔF508 CFTR did not express at the plasma membrane
in CNX KO MEF.
3.4. ΔF508 CFTR function in the epithelium of CNX KO/ΔF508 CFTR mice
Previous studies indicated that CFTR biosynthetic and trafﬁcking
mechanisms were cell type-dependent [38,39]. Thus, it is important toircuit current (Isc) data on colonic epithelium. The effects of sequential administration of
NX KO (C), and CNX KO/ΔF508 CFTR (D) colonic epithelium. The data are representative
epithelium, respectively. (E) CNX expression in the mouse tissue. Cell lysates fromwild-
th anti-CNX antibody.
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a polarized epithelial cell, which could be a suitable model reﬂecting
the physiological situation. To achieve this purpose, we generated theFig. 5. CNX assures the efﬁcient expression ofWT CFTR, but notΔF508 CFTR. (A, B) Effect of CNX
with Ad-CNXat theMOI indicated 24 h before infection of Ad-GFP-CFTRor-ΔF508CFTR. Forty-ei
blotting. (B) The intensity of the band of CFTR was quantiﬁed and expressed as a percentage of
against CNX-uninfected MEF. (C) GFP-ΔF508 CFTR interacts with CNX in MEF. WT MEF and CN
between GFP-ΔF508 CFTR and endogenous CNX (mouse) or exogenous CNX (human) was exam
anti-CNX antibody. (D, E) Proteasomal degradation ofWT CFTR, but notΔF508 CFTRwas enhanc
6 h before cell lysis. Cell lysates were analyzed by Western blotting (D), and the CFTR band w
Oligosaccharide-based interaction of CNX is involved in the stimulation of CFTR folding. CNX KO
infection.MEFwas treatedwith 1mMcastanospermine (CAS) for 24 h before cell lysis. Forty-eig
blotting. In CAS-treated cells, a lower molecular weight band (asterisk) was detected instead oCNX KO/ΔF508 CFTR mice and measured the short-circuit current (Isc)
as a CFTR functional marker in the colonic epithelium from CNX KO/
ΔF508 CFTR mice. We conﬁrmed the knock out of CNX in mice byintroduction into CNXKOMEF on the CFTRexpression.WTand CNXKOMEFwere infected
ght hours afterAd-GFP-CFTR infection, cell lysateswere prepared and analyzedbyWestern
the CFTR expression in CNX KO MEF (N=3–4). Statistical difference is shown as ⁎⁎Pb0.01
X KO MEF were infected with Ad-GFP-ΔF508 CFTR with or without Ad-CNX. Interaction
ined by immunoprecipitationwith anti-CFTR antibody, followed byWestern blotting with
ed by CNX KO.WTand CNX KOMEF expressing CFTRwere treatedwith 10 μMMG-132 for
as quantiﬁed and expressed as percentage of CFTR expression without MG-132 (E). (F)
MEFwas infectedwith Ad-CNX, Ad-CRTor Ad-LacZ at aMOI 100 24 h before Ad-GFP-CFTR
ht hours after Ad-GFP-CFTR infection, cell lysateswere prepared and analyzed byWestern
f the mature form. Hsc70 was used as loading control.
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murine colonic epithelia. The differences between WT and ΔF508
CFTR epithelia were particularly evident in Fig. 4A and B, where the Isc
increased after forskolin in the former, but decreased after the same
treatment in ΔF508 CFTR mouse tissues. Furosemide partially
reversed the Isc increase caused by forskolin in WT colons (Fig. 4A)
and completely reversed the forskolin effect in the ΔF508 CFTR colon
(Fig. 4B). The Isc recordings in the CNX KO mice colon (Fig. 4C) were
similar to WT colon (Fig. 4A), indicating that the CNX KO had no
signiﬁcant effect on transepithelial anion secretion. Similarly, the Isc
recordings obtained from CNX KO/ΔF508 CFTR mice colon were
similar to Isc recordings in ΔF508 CFTR mice (Fig. 4D). These results
clearly demonstrate that CNX KO fails to improve the ER retention and
function of ΔF508 CFTR in polarized epithelium.
3.5. CNX assures the efﬁcient expression of WT CFTR, but not ΔF508 CFTR
Our data showed that while CNX KO signiﬁcantly decreased the
steady state level of WT CFTR, it had no signiﬁcant effect on that of
ΔF508 CFTR (Fig. 2D). This result suggests that CNX may stimulate the
productive folding of WT CFTR, but not that of ΔF508 CFTR. To clarify
this possibility, we determined the effect of CNX introduction into
CNX KO MEF on CFTR. The recombinant adenovirus expressing CNX
(Ad-CNX) [29] was infected into CNX KO MEF 24 h before infection of
Ad-GFP-CFTR. Western blotting showed that CNX introduction
increased the steady state level of WT CFTR in a dose-dependent
manner (Fig. 5A-a,). Introduction of CNX signiﬁcantly increased the
steady state of WT CFTR, but not that of ΔF508 CFTR (Fig. 5A-b, B).
Immunoprecipitation experiment revealed that ΔF508 CFTR inter-
acted with exogenous human CNX in CNX KO MEF as well as
endogenous mouse CNX in WT MEF (Fig. 5C). These results indicate
that CNX assures the efﬁcient biosynthesis of WT CFTR, but not that of
ΔF508 CFTR.
CFTR reaches a proteasome-resistant conformation in the ER after
correct folding, which might be stimulated by chaperones [40]. To
determine whether CNX has the ability to stimulate the folding of WT
CFTR, but not that ofΔF508 CFTR, we examined the effect of MG-132, a
proteasome inhibitor, on the CFTR expression in CNX KOMEF.Western
blotting showed that similar to previous reports [15,16,29,41], MG-132
predominantly increased the ΔF508 CFTR expression (~2-fold),
indicating that ΔF508 CFTR underwent proteasomal degradation
(Fig. 5D (b) lanes 1, 4 and 5E). In contrast to ΔF508 CFTR, MG-132
did not increase the WT CFTR expression, indicating that WT CFTR
readily attained the proteasome-resistant conformation (Fig. 5D(a)
lanes 1, 4 and 5E). Interestingly, in CNX KOMEF, MG-132 increased the
WT CFTR by ~1.9-fold and its effect was nearly inhibited by the
introduction of CNX (Fig. 5D (a) lanes 2, 5, 3, 6 and 5E). Therefore, CNX
might be important for WT CFTR to achieve proteasome-resistant
conformation during productive folding. The effect of MG-132 on
ΔF508 CFTR expression in MEFs was not altered by CNX expression,
although it was slightly stronger in CNX KO MEF (~2.3-fold) than in
both WT MEF (~2.1-fold) and CNX KO MEF+CNX (~1.9-fold) (Fig. 5E).
These results strongly suggest that CNX might assist the productive
folding of WT CFTR, which can achieve native conformation
spontaneously, but not that of ΔF508 CFTR, which has a folding defect.
Finally, to examine the speciﬁcity of CNX, we tested the effect of
calreticulin (CRT), which is a homologue of CNX[42–45], on WT CFTR
expression in CNX KO MEF. Western blotting showed that while CNX
increasedWT CFTR expression, CRT failed to increase the expression of
WT CFTR compared with that in CNX KO MEF infected with
adenovirus expressing β-galactosidase (Ad-LacZ) as control adeno-
virus (Fig. 5F lanes 2, 3 and 4). Thus, CRT failed to compensate the
ability of CNX to assure the efﬁcient expression of WT CFTR.
Interestingly, the effect of CNX onWT CFTR expressionwas completely
inhibited by castanospermine (CAS) treatment, which prevents the
oligosaccharide-based CNX interactionwith substrates [46,47] (Fig. 5F,lane 5). These results strongly suggest that oligosaccharide-based CNX
interaction is required for the efﬁcient expression of WT CFTR.
4. Discussion
In this study, we clariﬁed that CNX is not necessary for the ER
retention of ΔF508 CFTR using our CNX KO system. Our data showed
that CNX KO did not affect the biosynthetic processing, cellular
localization nor regulated Cl− channel function of ΔF508 CFTR in CNX
KO MEF (Fig. 2 and 3), indicating that CNX KO failed to correct the ER
retention ofΔF508 CFTR. These resultswere consistentwith a previous
report showing that moderate CNX knockdown (60–70%) did not
correct the ΔF508 CFTR maturation measured by pulse-chase experi-
ment in CHO cells [30]. Since CNX KO did not affect the expression of
chaperones participating in the CFTR folding (Fig. 2A), failure of CNX
KO to correct the ER retention of ΔF508 CFTR was unlikely due to the
compensated function of the ER quality control machinery. In fact, we
could not detect the interaction of ΔF508 CFTR with BiP (data not
shown), which is involved in the second ER quality control mechanism
after release from CNX/CRT cycle [48]. Moreover, we could not detect
the interaction of ΔF508 CFTR with CRT (data not shown), and CAS
treatment, which abolished both CNX and CRT interaction with
substrates, had no effect on the ER retention of ΔF508 CFTR in CNX
KO MEF (data not shown). Thus, it is unlikely that ΔF508 CFTR in CNX
KOMEF is retained in the ER by CRT, whichmight be involved in the ER
retention of premature proteins in the CNX deﬁcient condition [47].
Since CFTR biosynthetic and trafﬁcking mechanisms are cell type-
dependent [38,39], we needed to examine the CNX KO effect on the
ΔF508 CFTR in a polarized epithelium, which might be a suitable
model reﬂecting the physiological condition. Similar to CNX KO MEF,
CNX KO failed to correct the function of ΔF508 CFTR in the polarized
colon epithelium from CNX KO/ΔF508 CFTR mice (Fig. 4). Therefore,
CNX seems not to be responsible for the ER retention of ΔF508 CFTR in
the polarized epithelium.
It has been suggested that CNX might be a target for developing a
therapeutic approach for CF and previous studies showed that the ER
retention of ΔF508 CFTR was corrected by compounds that could
affect its interaction with CNX[31–33]. However, it is likely that these
compounds might impact on other mechanisms that affect the folding
states of ΔF508 CFTR, resulting in the dissociation from CNX. Based on
our results, CNX might be not a target for developing a therapeutic
approach for CF.
It has been proposed that CNX is responsible for the ER retention of
several speciﬁc premature proteins since the CNX truncated mutant,
which leaves the ER to the post-Golgi compartments by the loss of ER
retention signal, induced the ER export of premature proteins [49,50].
Based on our data, however, CNX is not responsible for the ER
retention of ΔF508 CFTR. This interpretation might be supported by
the data showing that the CNX truncated mutant (CNXΔCYT) failed to
induce the ER export of ΔF508 CFTR (Fig. 1E and F). Although CNXwas
not responsible for the ER retention of ΔF508 CFTR, CNX might
interact with ΔF508 CFTR retained in the ER to attenuate the ERAD
since CNX overexpression increases the ER pool of ΔF508 CFTR [29].
This interpretation might be supported by our data showing that
introduction of CNX into CNX KO MEF slightly increased the ΔF508
CFTR expression (Fig. 5A, B). However, regardless of CNX expression,
ΔF508 CFTR underwent ERAD (Fig. 5D, E). Thus, most ΔF508 CFTR
might undergo ERAD by a CNX-independent pathway (e.g. Hsc/Hsp70-
CHIP pathway) as proposed previously [10]. A previous report showed
that CNX enhances the interaction of EDEM with CFTR, especially WT
CFTR to stimulate the glycan-dependent ERAD (GERAD) [10]. In our
study, however, CNX KO did not increase (rather it decreased) the WT
CFTR expression. Thus, CNX might not be necessary for the GERAD of
WT CFTR as well as ΔF508 CFTR. Alternatively, CNX KO might affect
the conformation of WT CFTR, resulting in the alteration of the
degradation pathway.
1593T. Okiyoneda et al. / Biochimica et Biophysica Acta 1783 (2008) 1585–1594ΔF508 CFTR might be retained by cytosolic chaperone complexes
such as Hsp90-AhaI rather than ER chaperones such as CNX. This is
reasonable because most CFTR domains are exposed in the cytosol and
ΔF508mutationmight result in the aberrant structure in the nucleotide
binding domain (NBD) 2 which is exposed in the cytosol [21].
Our data showed that CNX KO signiﬁcantly decreased the expression
of WT CFTR while it did not signiﬁcantly affect that of ΔF508 CFTR (Fig.
2C, D). Moreover, introduction of CNX into CNX KO MEF signiﬁcantly
enhanced the WT CFTR expression (Fig. 5A, B). Because human CNX,
instead of mouse CNX, introduced into CNX KO MEF increased the
expression of CFTR, human CNX seems to be able to compensate for the
function of mouse CNX in MEF. This is reasonable since human CNX is
91% homologous with mouse CNX. In contrast to WT CFTR, the effect of
CNX was less in the ΔF508 CFTR (Fig. 5A, B). Similar results were
obtained in our previous study showing that stabilization of immature
CFTR was achieved by lower-dose Ad-CNX (MOI 50 but not MOI 10) in
WT CFTR than that in ΔF508 CFTR (MOI 100) [29]. Therefore, it is likely
that CNX assures the efﬁcient biosynthesis of WT CFTR, but has less
impact on ΔF508 CFTR. Our data also showed that while the ability of
ΔF508 CFTR to attain a proteasome-resistant conformation was not
predominantly affected regardless of CNX expression, that of WT CFTR
was attenuated by CNX KO and restored by the introduction of CNX (Fig.
5D, E). These resultswere supported by a previous report showing that a
moderate CNX knockdown (60–70%) partially reduced the folding
efﬁciency of WT CFTR, but not that of ΔF508 CFTR, measured by pulse-
chase experiments [30]. Thus, we propose that CNXmight stimulate the
productive folding of substrates, such as WT CFTR, that can attain a
native conformation spontaneously. However, CNXmight not be able to
stimulate the productive folding of substrates, such as ΔF508 CFTR, that
harbor foldingdefects. In contrast to ourprevious report [11], CRThadno
effect on theWTCFTRexpression in CNXKOMEF (Fig. 5F). Thismight be
due to differences in cell models used. Alternatively, the negative effect
of CRT on WT CFTR expression we previously observed might have
affected the CNX expression.
Our data showed that CNX introduced into CNX KO MEF enhanced
theWT CFTR expression, but this effectwas completely inhibited by CAS
treatment, which prevented the oligosaccharide-based interaction of
CNX with substrates (Fig. 5F). Therefore, oligosaccharide-based interac-
tion of CNX might be important for stimulating the folding of WT CFTR.
CNX has a classical chaperone activity, which prevents protein aggrega-
tion through hydrophobic interaction [51]. However, non-glycosylated
CFTRmutant rapidly underwent ERAD [30] although the contribution of
CNX in the folding of non-glycosylated CFTR is unclear. Thus, in the case
of CFTR, rather than the hydrophobic interaction, oligosaccharide-based
interaction of CNX might be responsible for stimulating the productive
folding of protein, which is rarely exposed in the ER lumen.
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